In Opiates

Cannamed Events / by  / Feb 12, 2018

For far too long, opioid-based painkillers have been the go-to treatment for chronic pain of varying types. This practice has helped lay the foundation for the opioid crisis that ravages our nation today.

By now, you’ve likely heard the statistics, but they’re worth repeating. Of the approximately 20 million Americans struggling with a substance abuse disorder, nearly 2 million were related to the use of prescription painkillers. Drug overdose is now the leading cause of accidental death in the United States, with prescription opioid overdoses claiming the lives of 20,101 people in 2015 alone. Four out of five heroin users got initially hooked on prescription painkillers. And perhaps the most alarming figure of all; in 2012, physicians wrote almost 259 million prescriptions for opioid painkillers, enough to give every adult in America a bottle of pills.


Prescription opioids are most commonly ingested orally where they are absorbed in our digestive tract. Opioid-based painkillers mitigate pain by binding to one (or more) of the four types of opioid receptors found in our brains. Peak effects of opioids, when taken orally, occur in around 90 minutes and their effects last varying amounts of time depending on the dose and chemical composition of the medication. According to Dustin Sulak, DO, who presented at CannMed 2017, nearly 50 percent of opioid users were taking a short-acting opioid that put them at higher risk of abuse.

The current opioid crisis began due to a confluence of factors that appeared largely beginning in the 1990s. Those factors include physicians over-prescribing opioid-based painkillers, pharmaceutical companies promoting their products with dubious marketing practices, and patients abusing the medication they’d been prescribed. While there’s some consensus on what caused the problem, there’s less agreement on what can be done to solve it.

The most commonly proposed solutions center around improving coordination in healthcare delivery, community involvement, widespread use of alternative methods of pain management. Cannabis is one of these alternative methods, and it shows great potential in its abilities to treat chronic pain, fight the symptoms of opioid withdrawal, and even increase the efficacy of opioid treatment for patients with severe, long-lasting pain.

Wistia video thumbnail

Cannabis in Pain Management

Opioid receptors and cannabinoid receptors are both present in the region of the brain that signals the pain our bodies experience. These pathways have been shown to interact with each other and create similar pain-reduction effects. While opioid-based pain medications treat pain by binding to the opioid receptors in our brains, cannabis-based treatments work alongside our cannabinoid receptors to shutdown or inhibit our neural pathways that cause the sensation of pain.

Most research conducted into the use of cannabis-based derivatives in the treatment of pain have focused on acute pain. However, there is a small, growing amount of evidence to suggest that cannabinoids may be effective for the treatment of chronic pain. Due to cannabis’ classification as a Schedule I substance by the United States Food and Drug Administration, research into the potential of its use in the treatment of chronic pain is in its infancy; however, small-scale studies have shown considerable potential for further research. A review of 28 randomized clinical trials found “moderate-quality” evidence that cannabinoids were beneficial in treating chronic pain.

Cannabis and the Opioid Epidemic

Data presented at CannMed 2017 showed that cannabis is successful in reducing patients dependence on opioids. Dr. Sulak referenced a study conducted in Michigan with 244 medicinal cannabis patients suffering with chronic pain that found medicinal cannabis use was linked with a 64 percent reduction in opioid use and 45 percent improvement in overall quality of life.

Once a patient becomes dependent on opioid medications, it is difficult for many to cease opiate use due to their returning pain and the withdrawal symptoms that occur. Opioid withdrawal has a variety of symptomsthat are commonly described as mild to severe flu-like symptoms. Commonly occurring symptoms of opioid withdrawal include diarrhea, nausea, vomiting, rapid heartbeat, excessive sweating, dehydration, and seizures. Cannabis has been shown to be effective in combating these effects and decreasing the overall severity of withdrawal symptoms. A 2013 study published in Addiction Biology found that in rats, cannabis was able to decrease the reward-facilitating effects of morphine.

Fighting the opioid epidemic will require collaboration between medical professions, our communities, and the federal government. As pain management professionals in the United States work to ease people off opioid-based medications, new methods of treatment will need to be brought forth to take their place. For many individuals suffering with chronic pain, cannabis may be the answer. It’s up to patients, their physicians, and thought-leaders to advocate the federal government to reassess their stance on the medicinal use of cannabis in pain management.

The CannMed 2018 Conference is the perfect place to further the conversation about cannabis as an alternative pain management treatment. Researchers and medical professionals will present their latest findings on the topic. If you are interested in learning more about cannabis as an opioid alternative, join us at the UCLA Luskin conference center October for CannMed 2018.  Buy your tickets today!

Recent Posts